Corrigendum to “Clinical impact of the tumor immune microenvironment in completely resected stage IIIA(N2) non-small cell lung cancer based on an immunoscore approach”

Feng W, Li Y, Shen L, et al. Clinical impact of the tumor immune microenvironment in completely resected stage IIIA(N2) non-small cell lung cancer based on an immunoscore approach. Ther Adv Med Oncol 2021; 13: 1-14. DOI: 10.1177/1758835920984975

The authors of the above-mentioned paper have been informed post-publication that the term ‘immunoscore’ used in the paper is a trademarked term. The term has therefore been replaced in the title and six times throughout the text with the generic term ‘immunological score (IS)’, and the published version of the article has been changed to reflect this. The authors apologize for this error.